Neal Flomenberg MD Professor & Chair
Hematologic Oncology
Chairman, Department of Medical Oncology, Thomas Jefferson University & Hospital
Join to View Full Profile
925 Chestnut StSte 220Philadelphia, PA 19107
Phone+1 215-955-8874
Fax+1 215-955-2340
Dr. Flomenberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1980 - 1981
Jacobi Medical Center/Albert Einstein College of MedicineResidency, Internal Medicine, 1976 - 1979
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1976
Certifications & Licensure
DE State Medical License 2018 - 2027
NJ State Medical License 2018 - 2027
PA State Medical License 1994 - 2026
WI State Medical License 1991 - 1995
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Allscripts TouchWorks EHR, Allscripts, 2012-2013, 2015-2017
- CMS Meaningful Use Stage 1 Certification Allscripts TouchWorks EHR, Allscripts, 2012-2013, 2015-2017
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR (Complete), Allscripts, 2012-2013, 2015-2017
Clinical Trials
- Biological Therapy in Treating Patients With Multiple Myeloma That Has Recurred Following Bone Marrow Transplantation Start of enrollment: 1998 Jul 22
- Amifostine and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 1998 Jan 01
- Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma Start of enrollment: 2001 Nov 19
Publications & Presentations
PubMed
- The Heart of the Matter: Cardiac Toxicity in Allogenic Stem Cell Transplant with Post-Transplant Cyclophosphamide.Allison Gradone, Xia Bi, Satya Durugu, Alicia Bao, Boula Gattas
Transplantation and Cellular Therapy. 2026-01-01 - 1 citationsA Tender Reduced-Intensity Conditioning for the Unfit: A Novel 4 Gy Total Body Irradiation-Based Conditioning Followed by Two-Step Haploidentical Stem Cell Transplant,...Xia Bi, Dolores Grosso, Allison Gradone, Joanne Filicko-O'Hara, Kelly A McCorkell
Transplantation and Cellular Therapy. 2024-10-01 - 1 citationsA prospective study of posttransplant cyclophosphamide for unrelated donor peripheral blood stem cell transplant with special attention to graft content and the impact...Chetan Jeurkar, Benjamin Leiby, Shaik Rashid, Usama Gergis, Dolores Grossso
European Journal of Haematology. 2024-09-01
Journal Articles
- Final Outcomes of Escalated Melphalan 280 mg/m2 with Amifostine Cytoprotection Followed Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma: High C...Neal Flomenberg, Dianna S Howard, Barry R Meisenberg, Parameswaran Hari, Gordon L Phillips, David H Vesole, Jasleen Randhawa, Aaron P Rapoport, Nature
Press Mentions
Tevogen Reports Major Clinical Milestone: Expands HLA Coverage of Its Investigational Precision T Cell Therapy for Acute and Long COVIDNovember 6th, 2025- Tevogen Bio CSO to Discuss Investigational T Cell Therapy at NOLA Conference Focused on Long COVID and COVID-Related Cancer Risk, Alongside Leading Oncology ExpertsApril 26th, 2023
- Tevogen Bio Appoints Cell Therapy Expert Dr. Dolores Grosso as Global Clinical Development Lead to Accommodate Its Expanding PortfolioJanuary 4th, 2023
Professional Memberships
- Member
Other Languages
- Spanish, Tagalog, Turkish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
